Clinical
Latest News
Advertisement
Latest Videos
Advertisement
More News
The approval comes following phase 2 results of 119 patients who participated in the IMvigor210 study.
The European Respiratory Society and the American Thoracic Society have conducted a comprehensive review of evidence of managing exacerbations of chronic obstructive pulmonary disease in order to create a guideline of clinical recommendations.
A new collaboration between the Duke Clinical Research Institute, Duke University’s MURDOCK Study, and Boehringer Ingelheim Pharmaceuticals Inc will try to better understand how chronic obstructive pulmonary disease progresses in the real world.
Advertisement
Advertisement
Trending on AJMC
1
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
2
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
3
Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular Disease
4
Follitropin Delta Achieves Ongoing Pregnancy in 64% Under Age 35
5